THE ORGAN — VIII · The Modernization —

Trium Publishing House

Forensic System Architecture

thegipster.blogspot.com
Est. 2026 · Pennsylvania

The Organ

Post VIII of VIII · Series Complete

Final Post · Series Synthesis

The Modernization

2023 · Multi-Vendor Rebid · What Changed · What Didn't · What It Reveals

In 2023, Congress passed legislation ending UNOS's 37-year monopoly on the OPTN contract. The single award was broken into competitive components. Multiple vendors were selected. The governance structure was formally separated from the contractor. This is the right reform. Whether it is sufficient depends on what the system does with it — and whether the structural problems this series has documented are addressed by the new architecture or merely redistributed within it.

Contract Structure

Done

Single contract broken into competitive components · Multiple vendors awarded · 2023–2025

OPO Accountability

Active

2026 decertification cycle underway · First-ever consequence framework operative

Governance Independence

Partial

Board/contractor separation formal · Professional dominance of committees persists

Structural Architecture

Open

Core incentive problems — discard rate, coordinator model, data transparency — not yet resolved

01 What the 2023 Act Did

The Securing the US OPTN Act of 2023 addressed the most structurally visible problem this series has documented: the 37-year single-vendor contract. The legislation formally required HRSA to break the OPTN contract into functional components and award each competitively. It removed the funding cap that had kept the federal contract artificially small relative to UNOS's actual operational budget. It required separation of the OPTN board's governance function from the OPTN contractor's operational role — ending the structural merger of regulator and regulated that Post V documented.

By 2025, multiple vendors had been awarded pieces of what had been a single contract. UNOS retained some components — elements of the matching and data infrastructure where its institutional knowledge remained valuable. New contractors took over safety oversight, governance support, and other components. The monopoly, formally, ended.

These are real achievements. The legislation passed. The contracts were awarded. The structural separation that critics had called for over decades was implemented. The question this post addresses is what comes next — whether the new architecture resolves the problems the old one produced, or whether it is a necessary but insufficient first step toward a system that actually performs as it should.

Breaking a monopoly is not the same as fixing the system the monopoly governed. The 2023 reform addressed the contract architecture. The waitlist is still 103,000 patients. The discard rate is still 27%. The OPO performance gap is still 2:1. The Spain divergence still exists. The reform was necessary. It was not sufficient.

OPTN Modernization · Reform Component Assessment · 2025–2026 ORG-POST-VIII · RA-01

Component

What Was Done · What Remains

Status

Contract Competition

Single OPTN contract broken into five functional components: IT/matching, operations, safety oversight, governance support, research. Each competitively awarded. Multiple vendors selected. UNOS retained some data/IT work; new vendors took safety, governance, and other components.

CompleteStructural change achieved. First competitive awards in system history.

Governance Separation

OPTN board governance formally separated from OPTN contractor operations. Board no longer administered by the operating contractor. New board structure with expanded patient and public representation requirements.

UnderwayFormal separation achieved. Board composition reform ongoing. Professional community still substantially represented.

OPO Decertification

2020 CMS metrics reform first cycle complete. 2026 performance evaluation expected to identify multiple OPOs in Tier 1 (underperforming) status. First-ever decertification reviews possible. Territory reallocation framework in development.

Active 2026Metrics framework operative. Decertification follow-through is the test.

Data Transparency

IT contract separation intended to improve government access to OPTN data — ending the arrangement where the contractor controlled the federal data. New IT infrastructure in development. Public dashboard transparency goals stated but not fully achieved.

PartialGovernment data access improved. Full transparency not yet achieved.

Discard Rate

No direct structural change to the center incentive architecture that drives the 27% kidney discard rate. Outcomes reporting reform and new allocation policies have shown some improvement in kidney utilization in early data. Structural misalignment between center metrics and patient welfare not yet addressed.

MarginalEarly improvement signals. Core incentive architecture unchanged.

Coordinator Model

No reform toward the in-hospital embedded coordinator model Spain uses. OPOs retain the family approach function. External coordinator model unchanged. The structural innovation Spain built in 1989 and the US has studied for decades remains unimplemented.

Not AddressedStructural gap from Spanish model persists.

Safety Oversight

New safety contractor awarded — separating the oversight function from UNOS operations. 2025 HRSA review flagged concerning neurological assessment practices in some procurement cases. New safety structure intended to provide independent review that UNOS's self-oversight did not produce.

TransitioningNew oversight structure operative. Independence from transplant community being tested.

02 The Open Questions

The OPTN modernization is the beginning of a structural reform, not its completion. The questions that will determine whether the reform produces the outcomes the system exists to achieve are not yet answered. They are questions about implementation, institutional behavior, and political will — the hardest questions in any reform process.

Open Questions · OPTN Modernization · Determinative for Post-Reform Outcomes ORG-POST-VIII · OQ-01

01

Will the 2026 OPO decertification process follow through?

The 2020 CMS metrics reform created the first accountability framework in OPO history. The 2026 evaluation cycle is its first real test. If underperforming OPOs face genuine decertification and territory reallocation — rather than improvement plans and continued operation — it signals that the accountability mechanism is real. If not, the reform will have created a metrics framework without consequences, which is worse than no framework: it provides the appearance of accountability while the performance gap persists.

02

Does multi-vendor contracting produce accountability or just fragment it?

The single-contractor monopoly created one accountability problem: UNOS was too embedded and too powerful to be held responsible. The multi-vendor model creates a different risk: when five contractors share responsibility for the system, it may become possible for each to attribute failures to others, and for HRSA to struggle to coordinate across contractors in a life-critical real-time system. The 2023 reform solved the monopoly problem. Whether it created a coordination problem is the empirical question the next five years will answer.

03

Will the discard rate continue to fall?

Early data from 2024–2025 shows some improvement in kidney utilization rates — a modest but real signal that the combination of allocation policy changes, new metrics, and increased scrutiny may be shifting center behavior at the margins. Whether this improvement is durable, and whether it reaches the scale of the problem — thousands of viable kidneys discarded annually — is unresolved. The core incentive misalignment between center outcome metrics and patient welfare has not been structurally addressed.

04

Will the new governance board achieve real independence?

The formal separation of board governance from contractor operations is necessary but not sufficient for independence. The transplant professional community that dominated the old board continues to be the most technically expert, most institutionally engaged, and most consistently present voice in the governance process. Patient and public representatives who receive meaningful institutional support — staff resources, data access, technical assistance — will have genuine voice. Those who remain voluntarily appointed, under-resourced, and outmatched by professional expertise will not. The reform's governance achievement depends on investment in patient representation, not just formal requirements.

05

Will the US ever adopt the coordinator model?

Post VII documented that the US has studied the Spanish Model for decades without implementing its structural core. The 2023 reform addressed the UNOS monopoly. It did not address the OPO external coordinator model, the hospital relationship structure, or the financial incentive architecture that makes in-hospital coordinators structurally incompatible with the existing OPO system. Adopting the Spanish coordinator model would require hospitals to fund embedded coordinators, OPOs to surrender the family approach role, and the territorial monopoly structure to be redesigned. Nothing in the 2023 legislation addresses any of these requirements.

03 What the Architecture Reveals

The organ transplant system is a specific case of a general pattern in American healthcare governance. Complex, life-critical systems are delegated to private nonprofit organizations, governed by the professional communities they serve, funded by the entities they oversee, and insulated from reform by the genuine public benefit they provide. The pattern recurs across organ transplantation, blood banking, medical device oversight, pharmaceutical benefit management, and other domains where technical complexity and professional expertise concentrate governance in the hands of those with the most direct financial stake in its outcomes.

This series has documented the specific mechanisms through which that pattern produced its consequences in organ transplantation: the waitlist deaths, the discard rate, the OPO performance gap, the governance conflicts, the 37-year monopoly. Each mechanism was individually explicable. Each was defended by genuine arguments. Together they produced a system that saved hundreds of thousands of lives while failing to save tens of thousands more it could have reached.

The 2023 reform is the most significant structural change to the organ transplant system since NOTA. It was produced by a decade of sustained investigative journalism, congressional oversight, and patient advocacy — not by the system's internal accountability mechanisms, which had been documented as inadequate for years before the legislation passed. This sequence — public pressure eventually producing reform that institutional self-governance did not — is the pattern's closing argument.

49k⁺

Transplants 2024–25

Annual US transplant volume — a genuine life-saving achievement that coexists with the structural failures this series has documented

30

Deaths Per Day

Historical daily death rate on the transplant waitlist — the number that defines the system's unrealized potential alongside its achievements

2023

The Reform Moment

Year the 37-year monopoly formally ended — produced by journalism, congressional pressure, and patient advocacy, not by the system's own accountability mechanisms

FSA Note · System Disclosure

The organ transplant system discloses the same structural pattern this archive has documented across insurance, pharmaceuticals, media, and energy: private governance of public goods, insulated by genuine expertise, sustained by genuine public benefit, and resistant to accountability by the ordinary operation of institutional interest. The disclosure is not an indictment. The system has saved hundreds of thousands of lives. The disclosure is a description — of how a system designed to serve patients came to be governed primarily by the professionals and organizations whose interests were not always identical to patients', and of how the gap between those interests was maintained for 37 years by the most durable form of insulation: the fact that challenging the system risked harming the people it existed to protect. The 2023 reform is the beginning of the answer to that insulation. Whether it is sufficient is what the next decade will determine.

04 Series Record

The Organ · Series Record · FSA Findings · Eight Posts ORG-SERIES · RECORD-COMPLETE

I

The Algorithm

A private nonprofit held the federal contract to operate the entire US organ transplant system for 37 years — its algorithm determined who lived, and it was never seriously recompeted.

II

The List

The transplant waitlist is not a neutral queue but a managed architecture whose scoring systems embed racial and geographic inequity, and whose daily death toll is not random but the predictable output of allocation policy.

III

The Regional Monopoly

57 OPOs held exclusive procurement territories for decades without competition or decertification — the best converting 2:1 over the worst, with no consequence for the gap until 2020.

IV

The Discard

Between 20 and 29 percent of recovered kidneys are discarded annually — not because they are unusable but because center incentive structures make systematic declination rational for the center even when acceptance would be better for the patient.

V

The Board

The board that governed UNOS was constituted primarily by transplant professionals whose centers operated under the policies the board set — funded by the mandatory member fees those centers paid, the regulator was structurally captured from inception.

VI

The Contract

Two reasonable 1984 legislative decisions — private nonprofit contractor, mandatory membership — created the conditions for a single organization to accumulate 37 years of institutional lock-in that no administrative mechanism challenged until Congress acted.

VII

The Spain Divergence

Spain's 52+ donors per million, produced by organizational architecture rather than presumed consent law, demonstrates that the American system's failures are choices — the in-hospital coordinator model that produces Spain's results has been studied by the US for decades without being implemented, because it conflicts with the existing institutional arrangement.

VIII

The Modernization

The 2023 reform ended the monopoly and created the possibility of accountability — but left the core incentive problems unaddressed; whether it represents structural transformation or institutional redistribution is the open question the next decade will answer.

Series Closing Statement · The Organ · Trium Publishing House

The cooler on the warehouse floor is not a metaphor. It is a container. It holds something that was retrieved from a human body, in a hospital ICU, by an organization with exclusive territorial rights and no competitive accountability. It is traveling toward a patient on a waitlist of 103,000. Whether it arrives in time, whether it was accepted or declined by enough centers before the ischemia clock ran out, whether the patient who needed it is still alive to receive it — these outcomes are determined by an architecture that a private nonprofit governed for 37 years.

That nonprofit is no longer the sole contractor. The reform has happened. The architecture is being rebuilt. The cooler is still traveling.

30 patients died today waiting for an organ that the system, in some cases, could have recovered but didn't. In some cases could have placed but didn't. In some cases discarded rather than transplanted. These are not statistics. They are the system's daily output — the measure of the distance between what the architecture produces and what it could produce if it were built differently.

This series has tried to name that distance precisely.

Sub Verbis · Vera  ·  Beneath the words, the truth.
Randy Gipe · Claude / Anthropic · Trium Publishing House Limited · 2026

I II III IV V VI VII VIII

Series Complete · Eight Posts

Randy Gipe · Claude / Anthropic
2026 · Trium Publishing House Limited · Forensic System Architecture

Sub Verbis · Vera

FSA · The Organ · Series Complete